Published in Clinics (Sao Paulo) on August 01, 2017
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92
Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess (2004) 5.31
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22
Financial relationships in economic analyses of targeted therapies in oncology. J Clin Oncol (2012) 1.60
Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One (2008) 1.59
Cost-benefit of the telecardiology service in the state of Minas Gerais: Minas Telecardio Project. Arq Bras Cardiol (2011) 1.53
Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil. Malar J (2010) 1.25
Economic advantage of a community-based malaria management program in the Brazilian Amazon. Am J Trop Med Hyg (2001) 1.23
Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study. BMC Health Serv Res (2008) 1.00
Field evaluation of the performance and testing costs of a rapid point-of-care test for syphilis in a red-light district of Manaus, Brazil. Sex Transm Infect (2008) 0.98
Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil. Malar J (2012) 0.96
Cost effectiveness of positron emission tomography in patients with Hodgkin's lymphoma in unconfirmed complete remission or partial remission after first-line therapy. J Clin Oncol (2010) 0.96
Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis. BMC Infect Dis (2009) 0.96
Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why? Health Econ (2016) 0.96
Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature. Health Econ (2016) 0.92
New thinking on clinical utility: hard lessons for molecular diagnostics. Am J Manag Care (2014) 0.90
Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics (2008) 0.89
Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. PLoS One (2013) 0.88
Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection. Braz J Med Biol Res (2008) 0.88
[Technology assessment in health care: bone densitometry and alternative therapies in post-menopausal osteoporosis]. Cad Saude Publica (2003) 0.88
Cost-utility analyses of diagnostic laboratory tests: a systematic review. Value Health (2011) 0.87
An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil. An Bras Dermatol (2009) 0.85
Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. Clin Lymphoma Myeloma Leuk (2011) 0.85
Economic evaluation of strategies for managing women with equivocal cytological results in Brazil. Int J Cancer (2010) 0.84
Galactosaemia in a Brazilian population: high incidence and cost-benefit analysis. J Inherit Metab Dis (2009) 0.81
Economic evaluation of diagnostic tests. A review of published studies. Int J Technol Assess Health Care (1999) 0.80
A systematic review of model-based economic evaluations of diagnostic and therapeutic strategies for lower extremity artery disease. Thromb Haemost (2013) 0.80
The effect of identifying macroprolactinemia on health-care utilization and costs in patients with elevated serum prolactin levels. Value Health (2009) 0.79
Accuracy, risk and the intrinsic value of diagnostic imaging: a review of the cost-utility literature. Acad Radiol (2012) 0.79
Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting. Health Econ (2016) 0.78
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers. Appl Health Econ Health Policy (2016) 0.78
Estimate of the economic impact of implementing an in hospital protocol for the early detection and treatment of severe sepsis in public and private hospitals in southern Brazil. Rev Bras Ter Intensiva (2010) 0.78
Potential economic impact of the 21-gene expression assay on the treatment of breast cancer in Brazil. Rev Assoc Med Bras (2010) 0.77
[Cost-benefit analysis of ocular examination of patients with rosacea]. Arq Bras Oftalmol (2005) 0.77
[Angiography: safety x economy]. Arq Bras Oftalmol (2007) 0.77
[Characteristics of the demand for cranial computerized tomography: reasons and costs of the exam]. Arq Neuropsiquiatr (1992) 0.76
Comparison of the fluorescent polarization (TDx) and the enzymatic competitive (EMIT 2000) immune assays for the measurement of cyclosporin A blood concentration. Rev Hosp Clin Fac Med Sao Paulo (2001) 0.76
Systematic Review of Economic Evaluation of Health Technologies Developed In Brazil From 1980-2013. Value Health (2014) 0.76
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection. Int J Infect Dis (2005) 0.76
Prevention of cervical cancer in women with ASCUS in the Brazilian Unified National Health System: cost-effectiveness of the molecular biology method for HPV detection. Cad Saude Publica (2012) 0.76
Comparison between two strategies for rejection detection after heart transplantation: routine endomyocardial biopsy versus gallium-67 cardiac imaging. Transplant Proc (1997) 0.76
Malformations detected by abdominal ultrasound in children with congenital heart disease. Arq Bras Cardiol (2012) 0.76
Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil. Int J Tuberc Lung Dis (2013) 0.76
Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol. BMJ Open (2015) 0.75
Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review. PLoS One (2015) 0.75
A cost simulation for mammography examinations taking into account equipment failures and resource utilization characteristics. J Eval Clin Pract (2010) 0.75